Our Clinical Research

More than 100 clinical studies on the use of stem cells in neurology have been registered. By number of clinical trials involving multipotent mesenchymal stem cells (MMSCs), neurological conditions rank second only to bone and joint diseases. This interest stems from both the high prevalence of neurological disorders and the significant potential of stem cells as a treatment. Most studies are conducted on adult volunteers; however, in the case of cerebral palsy and autism, stem cell clinical trials are also conducted on children. Studies often use autologous cells isolated from the patient's own adipose tissue or bone marrow. Several studies have used stem cells isolated from umbilical cord tissue and cord blood. Donor material is used in studies evaluating its potential use in the acute and subacute phases of neurological disease.

Our clinics are members of the Scientific Association RUSCORD — an association of specialists and organizations working in the collection, storage, and use of umbilical cord blood cells and cell technologies.

We conduct both our own and global clinical trials on the use of cell-based products for treating a range of conditions.

Our Current Clinical Trials:

Safety and Efficacy of UCB Transfusion in ASD Patients Based on Degree of HLA Compatibility. (ASD-HLA2019)

ClinicalTrials.gov Identifier: NCT04099381

Stem Cell Clinical Research in Autism